Treatment of Acute Rhino-Sinusitis With Essential Oils of Aromatic Plants

HaEmek Medical Center, Israel14 enrolled

Overview

This randomized, double blind, parallel group study, compared the efficacy of spray containing aromatic essential oils of some herbal plants, against placebo in the treatment of patients with acute Rhino-sinusitis. Study objectives: Primary to demonstrate a relief in the nasal obstruction within 20 minutes after first administration of treatment with the spray. Secondary to demonstrate a reduction of a defined symptoms sum score based on symptoms and signs comparing baseline therapy from the beginning to the end of 3 days treatment

This study compared the efficacy of spray containing aromatic essential oils of Eucalyptus citriodora, Eucalyptus globulus, Mentha piperita, Origanum syriacum, and Rosmarinus Officinalis, against placebo in the treatment of patients with acute Rhino-sinusitis. In- vitro and clinical studies suggest therapeutic potential of aromatic herbs and trees oils in the treatment of Rhino-sinusitis. The pharmacological and clinical activity of Eucalyptus citriodora, Eucalyptus globulus, Mentha piperita, Origanum syriacum, and Rosmarinus Officinalis, include anti-inflammatory, anti-bacterial and anti-viral activities. Some of these herbs and trees oils have direct activity on the respiratory tract, the coughing reflex and the airflow in the nasal tract.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Rhino-Sinusitis

Interventions

mixture of aromatic essential oils.DIETARY_SUPPLEMENT

1% of mixture containing aromatic essential oils of Eucalyptus citriodora, Eucalyptus globulus, Mentha piperita, Origanum syriacum, and Rosmarinus Officinalis, spraying to the nose.

placeboDIETARY_SUPPLEMENT

0.1% of Lemon VIP (Florasynth,Israel), spraying to the nose.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of acute Rhino-sinusitis. * Active disease less than 96 hours * Patients agree to sign informed consent according to GCP and Israel national regulations. Exclusion Criteria: * Acute Sinusitis that need to get an antibiotically treatment . * Nasal polyposis. * Under any antibiotically treatment. * Asthma disease. * Under coumadine therapy. * Hyper sensitivity to Aromatic essential oils. * Any immuno-suppressive disease

Locations (1)

Otorhinolaryngology department

Afula, Israel

Outcomes

Primary Outcomes

To demonstrate a relief in the nasal obstruction within the first 20 minutes after first administration of treatment with the spray.

Time frame: 20 minutes

Secondary Outcomes

To demonstrate a reduction of a defined symptoms sum score based on symptoms and signs comparing baseline therapy from the beginning to the end of 3 days treatment.

Time frame: 3 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.